Bavarian Nordic — September 2024
-
Torsdagens danske avisuddrag med SAS, Ørsted, Vestas og Bavarian Nordic https://proinvestor.com/investornyt/1212508/torsdagens-danske-avisuddrag-med-sas-orsted-vestas-og-bavarian-nordic
-
Ja, det vil sikkert først blive hævet, hvis der kommer nogle gode MPOX aftaler i næste uge. Pt. afspejler kursmålet jo blot basisforretningen, som Nordea længe har ment var klart undervurderet på børsen.
-
Bavarian Nordic - Status for den globale mpox situation https://proinvestor.com/boards/122202
-
Tak for status @eliotspitzer
-
Bavarians koppevaccine beskytter moderat efter ét skud viser studie https://proinvestor.com/investornyt/1212527/bavarians-koppevaccine-beskytter-moderat-efter-et-skud-viser-studie
-
Bavarian Nordic Provides Update on the Mpox Vaccine Supply Situation
Bavarian Nordic Provides Update on the Mpox Vaccine Supply Situation
COPENHAGEN, Denmark, September 12, 2024 – Bavarian Nordic A/S (OMX: BAVA), the vaccine manufacturer of MVA-BN®, the only approved non-replicating smallpox...
GlobeNewswire News Room (www.globenewswire.com)
-
citat fra update: "UNICEF and Africa CDC have indicated that there is an urgent need for sufficient vaccine to protect up to 1 million people in the high-risk areas of the DRC, while potentially up to 10-12 million doses could be required through 2025...
-
..Bavarian Nordic is committed to ensuring equitable access to its mpox vaccine, and in response to the current outbreak and the strong demand from governments and organizations, including HERA, Gavi, UNICEF and Africa CDC, the Company has prioritized the production of MVA-BN for the rest of the year to provide up to 2 million doses by year-end. /
-
This decision has meant that certain existing orders for 2024 will be pushed out to 2025 to provide greater flexibility to fulfill additional urgent and imminent needs in other markets. While this will defer part of the planned revenue for 2024 into next year, new orders entered in the recent weeks will offset the deferred revenue, and thus the Company’s financial guidance for 2024 remains unchanged. /
-
These new supply contracts include multi-year agreements with countries across different continents, including countries who have pledged vaccines for Africa. In addition, Bavarian Nordic has responded to the UNICEF emergency tender, calling for the immediate supply of up to 2 million doses in 2024, and has ongoing discussions with other organizations and individual governments around the globe."
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind